DrugPatentWatch Database Preview

Flibanserin - Generic Drug Details

What are the generic drug sources for flibanserin and what is the scope of flibanserin freedom to operate?

Flibanserin is the generic ingredient in one branded drug marketed by Sprout Pharms and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Flibanserin has eighty-one patent family members in thirty-one countries.

One supplier is listed for this compound.

Summary for flibanserin

International Patents:	81
US Patents:	4
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	43
Clinical Trials:	16
Patent Applications:	411
Formulation / Manufacturing:	see details
DailyMed Link:	flibanserin at DailyMed

Pharmacology for flibanserin

Mechanism of Action	P-Glycoprotein Inhibitors

Synonyms for flibanserin

1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one
1-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one
1-(2-(4-alpha,alpha,alpha-Trifluoro-m-tolyl)-1-(piperazinyl)ethyl)-2-benzimidazolinone
1-(2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethyl)-1,3-dihydro-2H-benzimidazol-2-one
1,3-Dihydro-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-2H-benzimidazol-2-one
167933-07-5
2H-Benzimidazol-2-one, 1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-
2H-Benzimidazol-2-one,1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-
3-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-1H-benzimidazol-2-one
3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one
37JK4STR6Z
933F075
A810922
AC1OCF7H
Addyi
Addyi (TN)
AKOS005146139
AM84577
API0006409
AT-16920
BCP02131
Bimt 17
BIMT 17 BS
Bimt-17
BIMT-17-BS
CHEBI:90865
CHEMBL231068
CS-4671
D02577
DB04908
Female Viagra (Street Name)
Female Viagra [Street Name]
Flibanserin (USAN/INN)
Flibanserin [USAN:INN]
FT-0659246
Girosa
Girosa (proposed trade name)
GTPL8182
HSDB 8278
HY-A0095
KS-00000293
L001463
MolPort-006-170-023
NCGC00386567-01
SC-28449
SCHEMBL247579
UNII-37JK4STR6Z
ZINC52716421

US Patents and Regulatory Information for flibanserin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y	Y		➤ Sign Up
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for flibanserin

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
China	1571670	➤ Sign Up
China	1288147	➤ Sign Up
Slovenia	1414816	➤ Sign Up
Norway	20041588	➤ Sign Up
Japan	2007131631	➤ Sign Up
Croatia	P20040352	➤ Sign Up
Eurasian Patent Organization	200400252	➤ Sign Up
Country	Patent Number	Estimated Expiration